BRADLEY PHARMACEUTICALS ANNOUNCES AGREEMENT WITH DPT LABORATORIES

Bradley Pharmaceuticals has reached agreement with DPT Laboratories and its affiliate DPT Lakewood to continue manufacturing Zonalon, a topical dermatological preparation, and other products. Bradley recently acquired rights to Zonalon as part of an Aug. 10, 2004 acquisition of the business of Bioglan Pharmaceuticals Company, for whom DPT had been manufacturing Zonalon.

PR Newswire (http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/www/story/01-14-2005/0002828302&EDATE=)